Austin Health
🇦🇺Australia
- Country
- 🇦🇺Australia
- Ownership
- Private
- Established
- 1882-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- https://www.austin.org.au
Clinical Trials
196
Active:9
Completed:90
Trial Phases
6 Phases
Early Phase 1:1
Phase 1:11
Phase 2:40
+3 more phases
Drug Approvals
11
TGA:11
Drug Approvals
DeBug Chlorhexidine gluconate 5g/L in Isopropyl alcohol 70% v/v in an emollient base, topical solution bottle. (104241)
- Product Name
- DeBug Chlorhexidine gluconate 5g/L in Isopropyl alcohol 70% v/v in an emollient base, topical solution bottle.
- Approval Date
- Jun 29, 2004
TGA
AUSTIN HEALTH STANNOUS PYROPHOSPHATE Kit for preparation of Technetium {99mTc} stannous pyrophosphate powder for injection multidose vial (54211)
- Product Name
- AUSTIN HEALTH STANNOUS PYROPHOSPHATE powder for injection
- Approval Date
- Dec 12, 1995
TGA
AUSTIN HEALTH SUCCIMER Kit for preparation of Technetium {99mTc} succimer powder for injection multidose vial (54215)
- Product Name
- AUSTIN HEALTH SUCCIMER powder for injection
- Approval Date
- Dec 12, 1995
TGA
AUSTIN HEALTH Rhenium Colloid Kit for production of Technetium {99mTc} rhenium sulphide colloid injection composite pack (54196)
- Product Name
- AUSTIN HEALTH Rhenium Colloid composite pack
- Approval Date
- Dec 12, 1995
TGA
AUSTIN HEALTH FDG 2-deoxy-2-{18F}fluoro-D-glucose 3.7GBq-11.1GBq injection BP vial (54251)
- Product Name
- AUSTIN HEALTH FDG injection BP
- Approval Date
- Dec 12, 1995
TGA
AUSTIN HEALTH MEDRONATE Kit for preparation of Technetium {99mTc} medronate powder for injection multidose vial (54214)
- Product Name
- AUSTIN HEALTH MEDRONATE powder for injection
- Approval Date
- Dec 12, 1995
TGA
AUSTIN HEALTH PENTETATE Kit for preparation of Technetium {99mTc}pentetate powder for injection multidose vial (54210)
- Product Name
- AUSTIN HEALTH PENTETATE powder for injection
- Approval Date
- Dec 12, 1995
TGA
AUSTIN HEALTH DISOFENIN Kit for the preparation of Technetium {99mTc} disofenin powder for injection multidose vial (54204)
- Product Name
- AUSTIN HEALTH DISOFENIN powder for injection
- Approval Date
- Dec 12, 1995
TGA
AUSTIN HEALTH ANTIMONY SULPHIDE Kit for production of Technetium {99mTc} antimony sulphide colloid injection composite pack (54225)
- Product Name
- AUSTIN HEALTH ANTIMONY SULPHIDE composite pack
- Approval Date
- Dec 12, 1995
TGA
AUSTIN HEALTH CALCIUM PHYTATE Kit for preparation of Technetium {99mTc} calcium phytate injection composite pack (54223)
- Product Name
- AUSTIN HEALTH CALCIUM PHYTATE injection composite pack
- Approval Date
- Dec 12, 1995
TGA
- Prev
- 1
- 2
- Next
Clinical Trials
Distribution across different clinical trial phases (181 trials with phase data)• Click on a phase to view related trials
Not Applicable
91 (50.3%)Phase 2
40 (22.1%)Phase 4
26 (14.4%)Phase 3
12 (6.6%)Phase 1
11 (6.1%)Early Phase 1
1 (0.6%)Use of Water Ingestion in Small Intestine Ultrasound
Not yet recruiting
- Conditions
- Crohn Disease (CD)Intestine Ultrasonography
- First Posted Date
- 2025-07-22
- Last Posted Date
- 2025-07-22
- Lead Sponsor
- Austin Health
- Target Recruit Count
- 55
- Registration Number
- NCT07079007
- Locations
- 🇦🇺
Austin Health, Heidelberg, Victoria, Australia
Food Challenge at Home or in Medical Practice - the FoodCHOMP Study
Not Applicable
Recruiting
- Conditions
- Food Allergies
- First Posted Date
- 2025-04-08
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Austin Health
- Target Recruit Count
- 120
- Registration Number
- NCT06916819
- Locations
- 🇦🇺
Austin Health, Melbourne, Victoria, Australia
🇦🇺Royal Melbourne Hospital, Melbourne, Victoria, Australia
The ElectRx Study - A Neurotechnology Approach to the Treatment of IBD
Not Applicable
Recruiting
- Conditions
- Crohn Disease
- First Posted Date
- 2022-07-22
- Last Posted Date
- 2023-02-08
- Lead Sponsor
- Austin Health
- Target Recruit Count
- 13
- Registration Number
- NCT05469607
- Locations
- 🇦🇺
Austin Health, Melbourne, Victoria, Australia
The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge
Not Applicable
Completed
- Conditions
- Hypersensitivity, ImmediateHypersensitivity, DelayedHypersensitivity Response
- First Posted Date
- 2020-07-01
- Last Posted Date
- 2023-03-06
- Lead Sponsor
- Austin Health
- Target Recruit Count
- 382
- Registration Number
- NCT04454229
- Locations
- 🇺🇸
Duke University Medical Center, Durham, North Carolina, United States
🇺🇸Vanderbilt University Medical Center, Nashville, Tennessee, United States
🇦🇺Austin Health, Heidelberg, Victoria, Australia
Endoscopy-related Phone Consultation During the COVID-19 Outbreak
Completed
- Conditions
- Colon DiseaseColon PolypReflux, GastroesophagealVarices, Esophageal
- First Posted Date
- 2020-04-14
- Last Posted Date
- 2020-07-09
- Lead Sponsor
- Austin Health
- Target Recruit Count
- 186
- Registration Number
- NCT04344964
- Locations
- 🇦🇺
Austin Health, Melbourne, Victoria, Australia
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
News
Ribociclib (Kisqali) Added to PBS for Early-Stage Breast Cancer Patients in Australia
Ribociclib (Kisqali) is now subsidized on Australia's Pharmaceutical Benefits Scheme for early-stage breast cancer patients with hormone receptor-positive, HER2-negative disease at high risk of recurrence.